Graphique du cours de l'action SGP
SGP Dividendes
SpyGlass Pharma Inc
$0
0%
$0
À la fermeture : Aug 24, 16:00:00 GMT-4
$0
0%
$0
Post-Marché: Aug 24, 20:00:00 GMT-4
Retour
SpyGlass Pharma Inc (SGP) Dividendes
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
Rendement en dividend
--
BPA (TTM)
--
Capitalisation boursière
--
Qu’est-ce que SGP ?
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. The company is headquartered in Aliso Viejo, California and currently employs 65 full-time employees. The company went IPO on 2026-02-06. The firm is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
Fonctionnalités
© 2026 Edgen fonctionné par
